Airway gene transfer in a non-human primate: Lentiviral gene expression in marmoset lungs

N. Farrow; D. Miller; P. Cmielewski; M. Donnelley; R. Bright; D. W. Parsons

doi:10.1038/srep01287

Airway gene transfer in a non-human primate: Lentiviral gene expression in marmoset lungs

N. Farrow, D. Miller, P. Cmielewski, M. Donnelley, R. Bright, D. W. Parsons

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

9 Downloads (Pure)

Abstract

Genetic therapies for cystic fibrosis (CF) must be assessed for safety and efficacy, so testing in a non-human primate (NHP) model is invaluable. In this pilot study we determined if the conducting airways of marmosets (n = 2) could be transduced using an airway pre-treatment followed by an intratracheal bolus dose of a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector (LacZ reporter). LacZ gene expression (X-gal) was assessed after 7 days and found primarily in conducting airway epithelia as well as in alveolar regions. The LacZ gene was not detected in liver or spleen via qPCR. Vector p24 protein bio-distribution into blood was transient. Dosing was well tolerated. This preliminary study confirmed the transducibility of CF-relevant airway cell types. The marmoset is a promising NHP model for testing and translating genetic treatments for CF airway disease towards clinical trials.

Original language	English
Article number	1287
Number of pages	4
Journal	Scientific Reports
Volume	3
DOIs	https://doi.org/10.1038/srep01287
Publication status	Published - 15 Feb 2013
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/srep01287Licence: CC BY-NC-ND

Final published versionFinal published version, 747 KBLicence: CC BY-NC-ND

Cite this

@article{f4de1df69f3b49ee91fe7672a5ec36ce,

title = "Airway gene transfer in a non-human primate: Lentiviral gene expression in marmoset lungs",

abstract = "Genetic therapies for cystic fibrosis (CF) must be assessed for safety and efficacy, so testing in a non-human primate (NHP) model is invaluable. In this pilot study we determined if the conducting airways of marmosets (n = 2) could be transduced using an airway pre-treatment followed by an intratracheal bolus dose of a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector (LacZ reporter). LacZ gene expression (X-gal) was assessed after 7 days and found primarily in conducting airway epithelia as well as in alveolar regions. The LacZ gene was not detected in liver or spleen via qPCR. Vector p24 protein bio-distribution into blood was transient. Dosing was well tolerated. This preliminary study confirmed the transducibility of CF-relevant airway cell types. The marmoset is a promising NHP model for testing and translating genetic treatments for CF airway disease towards clinical trials.",

author = "N. Farrow and D. Miller and P. Cmielewski and M. Donnelley and R. Bright and Parsons, {D. W.}",

year = "2013",

month = feb,

day = "15",

doi = "10.1038/srep01287",

language = "English",

volume = "3",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Airway gene transfer in a non-human primate

T2 - Lentiviral gene expression in marmoset lungs

AU - Farrow, N.

AU - Miller, D.

AU - Cmielewski, P.

AU - Donnelley, M.

AU - Bright, R.

AU - Parsons, D. W.

PY - 2013/2/15

Y1 - 2013/2/15

N2 - Genetic therapies for cystic fibrosis (CF) must be assessed for safety and efficacy, so testing in a non-human primate (NHP) model is invaluable. In this pilot study we determined if the conducting airways of marmosets (n = 2) could be transduced using an airway pre-treatment followed by an intratracheal bolus dose of a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector (LacZ reporter). LacZ gene expression (X-gal) was assessed after 7 days and found primarily in conducting airway epithelia as well as in alveolar regions. The LacZ gene was not detected in liver or spleen via qPCR. Vector p24 protein bio-distribution into blood was transient. Dosing was well tolerated. This preliminary study confirmed the transducibility of CF-relevant airway cell types. The marmoset is a promising NHP model for testing and translating genetic treatments for CF airway disease towards clinical trials.

AB - Genetic therapies for cystic fibrosis (CF) must be assessed for safety and efficacy, so testing in a non-human primate (NHP) model is invaluable. In this pilot study we determined if the conducting airways of marmosets (n = 2) could be transduced using an airway pre-treatment followed by an intratracheal bolus dose of a VSV-G pseudotyped HIV-1 based lentiviral (LV) vector (LacZ reporter). LacZ gene expression (X-gal) was assessed after 7 days and found primarily in conducting airway epithelia as well as in alveolar regions. The LacZ gene was not detected in liver or spleen via qPCR. Vector p24 protein bio-distribution into blood was transient. Dosing was well tolerated. This preliminary study confirmed the transducibility of CF-relevant airway cell types. The marmoset is a promising NHP model for testing and translating genetic treatments for CF airway disease towards clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84874327954&partnerID=8YFLogxK

U2 - 10.1038/srep01287

DO - 10.1038/srep01287

M3 - Article

C2 - 23412644

AN - SCOPUS:84874327954

SN - 2045-2322

VL - 3

JO - Scientific Reports

JF - Scientific Reports

M1 - 1287

ER -

Airway gene transfer in a non-human primate: Lentiviral gene expression in marmoset lungs

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this